Form EFFECT Silexion Therapeutics
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 11, 2026 |
| Accession Number: | 0001178913-26-002446 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Maxim Group Downgrades Silexion Therapeutics (SLXN) to Hold
- Ambiq Expands Global Capital Markets Presence Through Singapore Exchange Mainboard Dual Listing
- CIEE Launches One World Café™, A Community Engagement Initiative for The U.S. Department of State's BridgeUSA Program
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
